ADVERTISEMENT

Clinical Summary

Breast cancer: vaginal oestrogen use with aromatase inhibitors increases recurrence risk

Deepa Koli   |   04 November 2022

Women with breast cancer receiving adjuvant endocrine therapy to reduce the risk for recurrence often report that the side effects of dampening down oestrogen, such as hot flashes and vaginal dryness, spoil their QoL, and these side effects can lead to discontinuation of therapy.

But medical measures to address these side...

          

November Challenge

Ends in 10h
left
right

Topic Challenges

left
right